<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Take two aspirin&#8230;</title>
	<atom:link href="http://blogs.reuters.com/reuters-dealzone/2008/09/09/take-two-aspirin/feed/" rel="self" type="application/rss+xml" />
	<link>http://blogs.reuters.com/reuters-dealzone/2008/09/09/take-two-aspirin/</link>
	<description>Behind the deals and deal-makers</description>
	<pubDate>Tue, 10 Nov 2009 13:05:17 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Deal Journal - WSJ.com : Afternoon Reading: Valuing Wall Street's Main Business</title>
		<link>http://blogs.reuters.com/reuters-dealzone/2008/09/09/take-two-aspirin/#comment-338235</link>
		<dc:creator>Deal Journal - WSJ.com : Afternoon Reading: Valuing Wall Street's Main Business</dc:creator>
		<pubDate>Tue, 09 Sep 2008 18:20:55 +0000</pubDate>
		<guid isPermaLink="false">http://blogs.reuters.com/reuters-dealzone/2008/09/09/take-two-aspirin/#comment-338235</guid>
		<description>[...] agro-chem and plastics businesses it might have to shed to make itself more Pfizer friendly,&#8221; writes Reuters&#8217;s DealZone. Yet based on the performance of Pfizer shares since its purchase of [...]</description>
		<content:encoded><![CDATA[<p>[...] agro-chem and plastics businesses it might have to shed to make itself more Pfizer friendly,&#8221; writes Reuters&#8217;s DealZone. Yet based on the performance of Pfizer shares since its purchase of [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
